ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 231 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $17,000 | +41.7% | 179 | -14.4% | 0.00% | – |
| Q3 2021 | $12,000 | +50.0% | 209 | +75.6% | 0.00% | – |
| Q2 2021 | $8,000 | 0.0% | 119 | 0.0% | 0.00% | – |
| Q1 2021 | $8,000 | 0.0% | 119 | +9.2% | 0.00% | – |
| Q4 2020 | $8,000 | -66.7% | 109 | -65.7% | 0.00% | – |
| Q3 2020 | $24,000 | +100.0% | 318 | +12.4% | 0.00% | – |
| Q2 2020 | $12,000 | 0.0% | 283 | 0.0% | 0.00% | – |
| Q1 2020 | $12,000 | -7.7% | 283 | 0.0% | 0.00% | – |
| Q4 2019 | $13,000 | -7.1% | 283 | -10.2% | 0.00% | – |
| Q3 2019 | $14,000 | -22.2% | 315 | 0.0% | 0.00% | – |
| Q2 2019 | $18,000 | +28.6% | 315 | 0.0% | 0.00% | – |
| Q1 2019 | $14,000 | 0.0% | 315 | -14.2% | 0.00% | – |
| Q4 2018 | $14,000 | +40.0% | 367 | +69.1% | 0.00% | – |
| Q3 2018 | $10,000 | +11.1% | 217 | 0.0% | 0.00% | – |
| Q2 2018 | $9,000 | 0.0% | 217 | 0.0% | 0.00% | – |
| Q1 2018 | $9,000 | – | 217 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |